日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice (PIONEER REAL Japan): Subgroup analyses

一项在日本临床实践中针对2型糖尿病成人患者开展的多中心、前瞻性、真实世界研究(PIONEER REAL Japan):亚组分析

Yabe, Daisuke; Hamamoto, Yoshiyuki; Kawanami, Daiji; Nishimura, Rimei; Terauchi, Yasuo; Amadid, Hanan; Braae, Uffe Christian; Major-Pedersen, Atheline; Suzuki, Ryo

Oral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies

口服索玛鲁肽治疗2型糖尿病:来自七项PIONEER REAL前瞻性真实世界研究的临床和患者报告结局汇总分析

Rudofsky, Gottfried; Amadid, Hanan; Braae, Uffe Christian; Catrina, Sergiu-Bogdan; Kick, Anastas; Mandavya, Kabirdev; Roslind, Klaus; Saravanan, Ponnusamy; van Houtum, William; Jain, Akshay B

PIONEER REAL Italy: Real-World Usage of Once-Daily Oral Semaglutide in Adults with Type 2 Diabetes

PIONEER REAL Italy:每日一次口服司美格鲁肽在2型糖尿病成人患者中的真实世界应用

Manti, Roberta; De Cosmo, Salvatore; Desenzani, Paolo; Ferrara, Lidia; Girelli, Angela; Memoli, Giuseppe; Bisio, Alessandro; Braae, Uffe Christian; Deinega, Alisa; Berra, Cesare

Time to Treatment Intensification with Glucagon-Like Peptide-1 Receptor Agonists Versus Comparators in People with Type 2 Diabetes Treated with Metformin

在接受二甲双胍治疗的 2 型糖尿病患者中,使用胰高血糖素样肽-1 受体激动剂与对照药物相比,强化治疗所需时间

Ostrominski, John W; Aroda, Vanita R; Braae, Uffe C; Kruse, Christian; Mandavya, Kabirdev; Buse, John B

Comparison of the effectiveness of fast-acting insulin aspart with rapid-acting insulin analogues on glycaemic control: a retrospective cohort study using patient data from primary care practices in England

比较速效胰岛素门冬与速效胰岛素类似物对血糖控制的疗效:一项基于英格兰初级保健机构患者数据的回顾性队列研究

Davies, Melanie J; Alibegovic, Amra Ciric; Jensen, Anders Boeck; Kelkar, Pranav; Nordsborg, Rikke Baastrup; Thamattoor, Usha K; Braae, Uffe Christian

PIONEER REAL UK: A Multi-Centre, Prospective, Real-World Study of Once-Daily Oral Semaglutide Use in Adults with Type 2 Diabetes

PIONEER REAL UK:一项多中心、前瞻性、真实世界研究,评估每日一次口服索马鲁肽在2型糖尿病成人患者中的应用

Saravanan, Ponnusamy; Bell, Heather; Braae, Uffe Christian; Collins, Edward; Deinega, Alisa; Dhatariya, Ketan; Machell, Alena; Trent, Antonia; Strzelecka, Anna

PIONEER REAL Japan: Primary results from a multicenter, prospective, real-world study of oral semaglutide in adults with type 2 diabetes in Japanese clinical practice

PIONEER REAL Japan:一项在日本临床实践中评估口服索玛鲁肽治疗2型糖尿病成人患者的多中心、前瞻性、真实世界研究的主要结果

Yabe, Daisuke; Hamamoto, Yoshiyuki; Kawanami, Daiji; Nishimura, Rimei; Terauchi, Yasuo; Amadid, Hanan; Braae, Uffe Christian; Major-Pedersen, Atheline; Suzuki, Ryo

Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes: The PIONEER REAL Switzerland Multicentre, Prospective, Observational Study

口服索玛鲁肽在2型糖尿病成人患者中的真实世界应用:PIONEER REAL瑞士多中心前瞻性观察研究

Kick, Anastas; M'Rabet-Bensalah, Khadija; Acquistapace, Flavio; Amadid, Hanan; Ambühl, Robert A; Braae, Uffe Christian; Item, Flurin; Schultes, Bernd; Züger, Thomas; Rudofsky, Gottfried

Real-World Use of Oral Semaglutide in Adults with Type 2 Diabetes in the PIONEER REAL Netherlands Multicentre, Prospective, Observational Study

PIONEER REAL荷兰多中心前瞻性观察研究:口服索玛鲁肽在2型糖尿病成人患者中的真实世界应用

van Houtum, William; Schrömbges, Patrick; Amadid, Hanan; van Bon, Arianne C; Braae, Uffe C; Hoogstraten, Charlotte; Herrings, Hans

PIONEER REAL Sweden: A Multicentre, Prospective, Real-World Observational Study of Oral Semaglutide Use in Adults with Type 2 Diabetes in Swedish Clinical Practice

PIONEER REAL Sweden:一项在瑞典临床实践中,针对2型糖尿病成人患者使用口服索玛鲁肽的多中心、前瞻性、真实世界观察性研究

Catrina, Sergiu-Bogdan; Amadid, Hanan; Braae, Uffe C; Dereke, Jonatan; Ekberg, Neda Rajamand; Klanger, Boris; Jansson, Stefan